Events & Presentations

June 9th, 2021 LD Micro Invitational
> Download Presentation
May 21st, 2021 Orphan Disease Presentation May 2021
> Download Presentation
May 13th, 2021 Processa Pharmaceuticals First Quarter 2021 Earnings Call
> Conference Call Replay
May 13th, 2021 Processa Pharmaceuticals First Quarter Results and Clinical Pipeline Update
> Download Presentation
March 25th, 2021 Processa Pharmaceuticals Fourth Quarter Results and Drug Development Update
> Conference Call
March 25th, 2021 Clinical Pipeline Update March 2021
> Download Presentation
January 11th, 2021 Corporate Presentation January 2020
> Download Presentation
November 12th, 2020 Clinical Pipeline Update November 2020
> Download Presentation
November 12th, 2020 Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on Nov. 12 at 5:30 p.m. ET
> Conference Call
May 28th, 2020 Corporate Presentation May 2020
> Download Presentation
January 14th, 2020 Corporate Presentation January 2020
> Download Presentation
October 22nd, 2019 Corporate Presentation October 2019
> Download Presentation
June 7th, 2019 Processa will be presenting at the Jefferies Healthcare Conference
New York, NY
June 4 - 7, 2019
> Download Processa Pharmaceuticals Jefferies Healthcare Conference Presentation
March 13th, 2019 Processa will be presenting at the Cowen Conference
Marriott Copley
77-750 Avenue 50
La Quinta, CA 92253
9:20AM followed by a breakout session at 10:00AM
Wednesday, March 13, 2019
> Download Processa Pharmaceuticals Cowen Conference Presentation
February 23rd, 2019 The Desert Conference
La Quinta Country Club
77-750 Avenue 50
La Quinta, CA 92253
11:30 AM
Saturday, February 23, 2019
> Download Processa Pharmaceuticals Desert Presentation
January 9, 2019 Study Design and Preliminary Safety Tolerability of PCS499 for the Treatment of Necrobiosis Lipoidica
> Download Presentation
June 4-6, 2018 LD Micro 8th Invitational
June 4-6, 2018
Belair, CA
> Download Processa Pharmaceuticals LD Micro Presentation
Mar 21, 2018 Processa Pharmaceuticals Announces That It Has Been Assigned The License For The Clinical Stage Compound Ctp-499 And Plans To Develop The Drug In Multiple Unmet Medical Need Conditions
Mar 11-14, 2018 Roth Capital Partners Annual Conference
March 11-14, 2018
Orange County, CA
> Download Processa Pharmaceuticals Roth Conference Presentation
Dec 5, 2017 Processa Pharmaceuticals December 2017 Corporate Presentation

Jan 8-11, 2018

Attending and Meeting Investors
J.P. Morgan 36th Annual Healthcare Conference
January 8-11, 2018
San Francisco, California
Dec 5, 2017 10th Annual LD Micro Main Event
Tuesday, Dec 5 at 1:30-2:00 PM in Track 5
Presenter: Patrick Lin, David Young
Los Angeles, California
Nov 13-15, 2017 3rd Annual Emerging Growth Conference
November 13-15, 2017
Rancho Santa Fe, California